|
ATXN2L expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.377400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.786900E-04 |
| Normal-vs-Stage2 |
6.299800E-02 |
| Normal-vs-Stage3 |
5.317700E-02 |
| Normal-vs-Stage4 |
2.12690000001015E-06 |
| Stage1-vs-Stage2 |
4.246800E-01 |
| Stage1-vs-Stage3 |
3.646500E-02 |
| Stage1-vs-Stage4 |
2.363700E-03 |
| Stage2-vs-Stage3 |
6.137400E-01 |
| Stage2-vs-Stage4 |
9.179900E-03 |
| Stage3-vs-Stage4 |
2.969800E-04 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.9637999999993E-05 |
| Normal-vs-AfricanAmerican |
8.443800E-03 |
| Normal-vs-Asian |
5.72770000000222E-05 |
| Caucasian-vs-AfricanAmerican |
9.560000E-01 |
| Caucasian-vs-Asian |
1.668440E-01 |
| AfricanAmerican-vs-Asian |
3.548800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.757300E-04 |
| Normal-vs-Female |
1.504390E-03 |
| Male-vs-Female |
3.979400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.210900E-04 |
| Normal-vs-Age(41-60Yrs) |
6.064600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.123720E-03 |
| Normal-vs-Age(81-100Yrs) |
7.584000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.402600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.996800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.976410E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.261000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.293200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.339600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.030200E-01 |
| Classical-VS-Follicular |
1.81651999999755E-05 |
| Classical-VS-Other |
8.755800E-01 |
| Classical-VS-Normal |
1.6719599999937E-05 |
| Tall-VS-Follicular |
1.637180E-01 |
| Tall-VS-Other |
6.217200E-01 |
| Tall-VS-Normal |
3.205600E-02 |
| Follicular-VS-Other |
2.406600E-01 |
| Follicular-VS-Normal |
4.802400E-01 |
| Other-VS-Normal |
8.355500E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.280500E-03 |
| Normal-vs-N1 |
9.51940000000207E-05 |
| N0-vs-N1 |
1.480300E-02 |
|
|
